An assessment of the usefulness of serum periostin, as a predictor for omalizumab induction in future: Follow-up study of KiHAC population
Sunadome H, Matsumoto H, Tohda Y, Horiguchi T, Kita H, Kuwabara K, Tomii K, Ohtsuka K, Masaki Fujimura, Ohkura N, Iwanaga T, Hozawa S, Niimi A, Kanemitsu Y, Nagasaki T, Tashima N, Morimoto C, Ishiyama Y, Oguma T, Tajiri T, Ito I, Ono J, Ohta S, Izuhara K, Hirai T.
European Academy of Allergy and Clinical Immunology Congress, 2019年06月03日